SEI Investments
TBPH icon

SEI Investments’s Theravance Biopharma TBPH Stock Holding History

SEI Investments’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$252K Sell
14,845
-2,100
-12% -$34.8K ﹤0.01% 2941
2026
Q1 		$275K Sell
16,945
-23,775
-58% -$421K ﹤0.01% 2852
2025
Q4 		$762K Buy
+40,720
New +$675K ﹤0.01% 2312
2021
Q3 		– Sell
-31,812
Closed -$462K – 2628
2021
Q2 		$462K Sell
31,812
-448
-1% -$8.41K ﹤0.01% 2137
2021
Q1 		$658K Sell
32,260
-681
-2% -$12.9K ﹤0.01% 1916
2020
Q4 		$585K Buy
32,941
+9,587
+41% +$172K ﹤0.01% 1913
2020
Q3 		$345K Sell
23,354
-722
-3% -$13.5K ﹤0.01% 2048
2020
Q2 		$505K Buy
+24,076
New +$618K ﹤0.01% 1843
2018
Q2 		– Sell
-8
Closed – – 3778
2018
Q1 		$0 Hold
8
– – ﹤0.01% 3665
2017
Q4 		$0 Hold
8
– – ﹤0.01% 3483
2017
Q3 		$0 Hold
8
– – ﹤0.01% 3386
2017
Q2 		$0 Hold
8
– – ﹤0.01% 3277
2017
Q1 		$0 Hold
8
– – ﹤0.01% 3080
2016
Q4 		$0 Hold
8
– – ﹤0.01% 3044
2016
Q3 		$0 Buy
8
+6
+300% +$167 ﹤0.01% 2992
2016
Q2 		$0 Hold
2
– – ﹤0.01% 2749
2016
Q1 		$0 Hold
2
– – ﹤0.01% 2637
2015
Q4 		$0 Sell
2
-9
-82% -$143 ﹤0.01% 2677
2015
Q3 		$0 Hold
11
– – ﹤0.01% 2577
2015
Q2 		$0 Hold
11
– – ﹤0.01% 2357
2015
Q1 		$0 Hold
11
– – ﹤0.01% 2354
2014
Q4 		$0 Buy
+11
New +$192 ﹤0.01% 2259

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
ICM
Irenic Capital Management New York $2.08B AUM 19.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

SEI Investments's TBPH Position: Q2 2026 in Review

SEI Investments reduced its Theravance Biopharma (TBPH) stake by 12% in Q2 2026, selling an estimated $34.8K and leaving 14,845 shares worth $252K. The position accounts for ﹤0.01% of the portfolio, ranked #2941.

SEI Investments first reported a position in TBPH in Q4 2014 and has held it in 22 quarters since. The position peaked at $762K in Q4 2025. 180 funds tracked by Wall St. Rank hold TBPH as of Q2 2026.

  • SEI Investments held 14,845 shares of Theravance Biopharma worth $252K as of Q2 2026.
  • SEI Investments sold 2,100 Theravance Biopharma shares in Q2 2026, an estimated $34.8K.
  • Theravance Biopharma made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2941 holding.
  • SEI Investments first reported a position in Theravance Biopharma in Q4 2014 and has held it in 22 quarters since.
  • SEI Investments's Theravance Biopharma position peaked at $762K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Theravance Biopharma as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.